GOSSAMER DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GOSS

Rosen Law Firm is notifying investors in Gossamer Bio, Inc., FS KKR Capital Corp., and Regencell Bioscience Holdings Limited of ongoing securities class action lawsuits. The firm is seeking lead plaintiffs with losses exceeding $100,000 before the June 1, 2026 deadline. The Gossamer case alleges defendants made false statements about their Phase 3 PROSERA study design while concealing material adverse facts.